Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Dr Mark Gorden ,Director at Boehringer Ingelheim Pharmaceuticals.His international experience includes various programes,contributions and participation in different countries for diverse fields of study.His research intrests reflect in his wide range of publications in various national and international journals.
Mark researches and develops new therapies for Parkinson’s disease (PD) and cognitive impairments, such as Alzheimer’s disease. He is the clinical program leader of an international development project in PD. Mark represents BI on external consortia focusing on patient reported outcomes, biomarkers, and disease progression models.
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals